SCHEMBL20141276

SCHEMBL20141276

Cc1cc(C)c(C(=O)OC(C)(C)C)c(C)c1NC1CCN(c2ccc(F)cn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTOR P42345 3/20 0.54
RPTOR Q8N122 3/20 0.54
MLST8 Q9BVC4 3/20 0.54
PPARG P37231 1/20 0.43
HRH3 Q9Y5N1 3/20 0.43
SYK P43405 2/20 0.40
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
SMO Q99835 2/20 0.38
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
GPR119 Q8TDV5 1/20 0.37
WNT3A P56704 1/20 0.37
TDO2 P48775 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LCAT P04180 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22187892 0.94 MTOR (0.53) MTORRPTORMLST8PPARGHRH3
SCHEMBL20141052 0.87 MTOR (0.58) MTORRPTORMLST8PPARGHRH3
SCHEMBL21360332 0.86 MTOR (0.57) MTORRPTORMLST8PPARGHRH3
SCHEMBL20141229 0.85 GPR119 (0.52) MTORRPTORMLST8HRH3CKS1B
SCHEMBL22187985 0.85 MTOR (0.65) MTORRPTORMLST8PPARGHRH3
Hydrochloric Acid SCHEMBL20141078 0.85 MTOR (0.56) MTORRPTORMLST8PPARGHRH3
SCHEMBL20141232 0.83 GPR119 (0.52) MTORRPTORMLST8GPR119KDM4E
SCHEMBL21360314 0.81 MTOR (0.61) MTORRPTORMLST8GPR119
SCHEMBL20141336 0.81 MTOR (0.54) MTORRPTORMLST8
SCHEMBL22188069 0.80 MTOR (0.63) MTORRPTORMLST8HRH3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.